Pancreatic cancer breakthrough: New drug approved

Dr. Brian Wolpin explains how patients can access the newly FDA-approved pancreatic cancer drug Rasonque. Instead of needing to be on a clinical trial, oncologists can now write prescriptions for this life-extending pill.

Patients seeking treatment can now access the landmark pancreatic cancer drug Rasonque directly through a prescription. Dr. Brian Wolpin explains that FDA approval removes the requirement for clinical trials, allowing oncologists to prescribe the pill directly.